ro 46-2005 has been researched along with a 81988 in 1 studies
Studies (ro 46-2005) | Trials (ro 46-2005) | Recent Studies (post-2010) (ro 46-2005) | Studies (a 81988) | Trials (a 81988) | Recent Studies (post-2010) (a 81988) |
---|---|---|---|---|---|
26 | 0 | 1 | 17 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calzadilla, SV; Chiou, W; Dayton, BD; Dixon, DB; Hernandez, L; Hoffman, DJ; Kester, JA; Marsh, KC; Nellans, HN; Opgenorth, TJ; von Geldern, TW; Wu-Wong, JR | 1 |
1 other study(ies) available for ro 46-2005 and a 81988
Article | Year |
---|---|
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption.
Topics: Administration, Oral; Animals; Azepines; Azoles; Drug Design; Endothelin Receptor Antagonists; Hydrogen Bonding; Indicators and Reagents; Indoles; Injections, Intravenous; Intestinal Absorption; Kinetics; Male; Metabolic Clearance Rate; Models, Biological; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Structure-Activity Relationship | 1996 |